Montana Telehealth Prescribing: Establishing a Valid Provider-Patient Relationship

Telehealth has rapidly expanded access to healthcare across the United States, but each state maintains its own regulatory framework governing its practice, particularly concerning the establishment of a provider-patient relationship and the prescribing of medications. Montana, like many states, has adopted specific statutes and administrative rules to ensure patient safety and maintain standards of care in the evolving landscape of virtual healthcare. For any healthcare business operating via telehealth in Montana, a thorough understanding of these regulations is paramount.

Understanding Montana's Telehealth Framework

Montana's primary legal framework for telehealth is found in Montana Code Annotated (MCA) Title 37, Chapter 29, Part 1, which defines key terms and establishes general principles. Specifically, MCA § 37-29-102(8) defines "telehealth" as the use of synchronous or asynchronous telecommunications technology by a health care provider to provide health care services, including but not limited to assessment, diagnosis, consultation, treatment, and transfer of medical data. This broad definition allows for various modalities, but the subsequent rules often clarify the acceptable technology for specific types of interactions, especially when prescribing is involved.

Crucially, Montana law generally permits the establishment of a provider-patient relationship via telehealth. However, this is not an open invitation for superficial interactions. The standard of care for a telehealth encounter is expected to be equivalent to an in-person encounter. This means that providers must conduct an appropriate evaluation, gather sufficient patient history, and utilize technology that allows for a medically sound assessment.

Establishing a Valid Provider-Patient Relationship for Prescribing

The cornerstone of responsible prescribing, whether in-person or via telehealth, is a valid provider-patient relationship. Montana's professional licensing boards, such as the Board of Medical Examiners, the Board of Nursing, and the Board of Pharmacy, issue rules that elaborate on the statutory requirements. These rules often emphasize that the relationship must be established through a process that includes:

• Patient Consent: Obtaining informed consent from the patient for telehealth services.
• Patient Evaluation: Conducting a thorough patient evaluation, which typically requires real-time interactive audio-visual communication. For certain conditions or medications, an initial in-person examination may be necessary.
• Medical Record Documentation: Maintaining comprehensive medical records for all telehealth encounters, equivalent to those for in-person visits.
• Continuity of Care: Ensuring a plan for follow-up care, referrals, and access to emergency services when appropriate.

Prescribing Controlled Substances via Telehealth

Prescribing controlled substances via telehealth is often subject to stricter scrutiny and additional requirements. While the federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before prescribing controlled substances via the internet, the COVID-19 Public Health Emergency (PHE) waivers temporarily allowed for prescribing without an initial in-person visit. However, these waivers have expired, and the Drug Enforcement Administration (DEA) has been working on new permanent rules. Montana's state-level regulations often align with or supplement federal requirements.

For instance, the Montana Board of Medical Examiners Administrative Rules of Montana (ARM) 24.156.1601 et seq., particularly ARM 24.156.1603, addresses the practice of telemedicine. While it generally allows for the establishment of a patient relationship via telemedicine, it implicitly requires that the standard of care be met. For controlled substances, especially Schedule II and III, an in-person examination may be required unless specific exceptions apply or the DEA's final rules provide a clear pathway for fully virtual prescribing under certain conditions. Providers must remain vigilant regarding the latest federal DEA rules in conjunction with Montana's state-specific mandates.

Key Considerations for Prescribing Medications

Regardless of whether a substance is controlled, providers must adhere to the following principles when prescribing via telehealth in Montana:

• Appropriate Evaluation: The evaluation must be sufficient to diagnose the patient's condition and justify the prescribed medication. This often necessitates real-time audio-visual technology to adequately assess the patient.
• Verification of Patient Identity: Robust processes must be in place to verify the identity of the patient receiving care.
• Prescription Monitoring Program (PMP) Checks: For controlled substances, providers are generally required to check the Montana Prescription Drug Registry (PDR) before prescribing, as outlined in MCA § 37-7-1502.
• Referral and Collaboration: Providers should be prepared to refer patients for in-person care or collaborate with local providers if the complexity of the patient's condition warrants it or if a telehealth evaluation is insufficient.

Regulatory Enforcement and Compliance

Failure to comply with Montana's telehealth and prescribing laws can lead to severe consequences for providers and healthcare businesses. These may include:

• Disciplinary Action: Professional licensing boards can impose sanctions ranging from fines and reprimands to license suspension or revocation.
• Civil Penalties: Violations may result in civil lawsuits for malpractice or negligence.
• Criminal Charges: Unlawful prescribing, especially of controlled substances, can lead to criminal prosecution.
• Exclusion from Federal Healthcare Programs: Violations related to fraud or abuse can lead to exclusion from Medicare and Medicaid.

Healthcare businesses must implement comprehensive compliance programs that include regular training for providers on Montana's specific telehealth regulations, robust technological infrastructure to support secure and effective telehealth encounters, and clear policies and procedures for establishing and maintaining provider-patient relationships and prescribing medications.

Conclusion

Montana's regulatory landscape for telehealth prescribing emphasizes patient safety and adherence to the standard of care. While telehealth offers incredible opportunities for expanding access to care, providers and healthcare businesses must meticulously follow state statutes and administrative rules regarding the establishment of a valid provider-patient relationship. This includes understanding the nuances of prescribing controlled versus non-controlled substances, utilizing appropriate technology for patient evaluations, and maintaining thorough documentation. Staying informed about both state and federal regulatory changes, particularly concerning the DEA's stance on controlled substance prescribing via telehealth, is essential for compliant and successful operations in Montana.

Source:

• Montana Code Annotated, Title 37, Chapter 29, Part 1: Telehealth. https://leg.mt.gov/bills/mca/title_0370/chapter_0290/part_0010/sections_index.html
• Administrative Rules of Montana, Title 24, Chapter 156, Subchapter 16: Telemedicine (Board of Medical Examiners). https://rules.mt.gov/gateway/ChapterHome.asp?Chapter=24.156
• Montana Code Annotated, Title 37, Chapter 7, Part 15: Prescription Drug Registry. https://leg.mt.gov/bills/mca/title_0370/chapter_0070/part_0150/sections_index.html